It might spread to your back or seem to ease off, but it’s not something to brush aside. Aortic dissection is one of those rare, dangerous conditions that can strike without warning and escalate ...

Differential aortic aneurysm formation provoked by chemogenetic oxidative stress. Journal of Clinical Investigation , 2025; 135 (9) DOI: 10.1172/JCI188743 Cite This Page : ...

Patency or thrombosis of the false lumen in type B acute aortic dissection has been found to predict outcomes. The prognostic implications of partial thrombosis of the false lumen have not yet ...

Get Instant Summarized Text (Gist) The FDA has approved the SAPIEN 3 TAVR platform for patients with severe asymptomatic aortic stenosis. In a median 3.8-year follow-up, TAVR reduced the combined ...

Aortic stenosis is a progressive and potentially fatal condition, affecting about five per cent of 65-year-olds in the US -- with increasing prevalence in advancing age. Symptoms include chest ...

This innovative technique provides new hope for patients with complex, life-threatening aortic aneurysms who previously had limited treatment options. Kim Baker, senior vice president of hospital ...

Data on the frequency of repair of intact (nonruptured) abdominal aortic aneurysms, in-hospital mortality among patients who had undergone aneurysm repair, and rates of aneurysm rupture during the ...

A transcatheter aortic valve replacement platform was approved for severe asymptomatic aortic stenosis. Edwards Lifesciences’ TAVR platform is the first to be approved in this population.

Asymptomatic patients with severe aortic stenosis can now undergo transcatheter aortic valve replacement, thanks to the US Food and Drug Administration’s approval of the new indication for the balloon ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis early in the disease process while patients still had no symptoms or other ...